Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q57629092 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241121000211.0 | ||
008 | 241121nneanz||abbn n and d | ||
035 | ‡a (WKP)Q57629092 | ||
024 | ‡a 0000-0001-7096-0718 ‡2 orcid | ||
035 | ‡a (OCoLC)Q57629092 | ||
100 | 0 | ‡a M Williams ‡9 nl ‡9 es ‡9 ast | |
400 | 0 | ‡a Matt Williams ‡c researcher ORCID ID = 0000-0001-7096-0718 ‡9 en | |
670 | ‡a Author's A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma | ||
670 | ‡a Author's Aggregating evidence about the positive and negative effects of treatments. | ||
670 | ‡a Author's Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival. | ||
670 | ‡a Author's Computer Programming: Should Medical Students Be Learning It? | ||
670 | ‡a Author's Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients | ||
670 | ‡a Author's Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomes | ||
670 | ‡a Author's Glioblastoma in England: 2007-2011. | ||
670 | ‡a Author's Integrated systems-genetic analyses reveal a network target for delaying glioma progression | ||
670 | ‡a Author's Malignant spinal cord compression: NICE guidance, improvements and challenges | ||
670 | ‡a Author's Radiotherapy might not be the answer in Africa | ||
670 | ‡a Author's Routine clinical data predict survival after palliative radiotherapy: an opportunity to improve end of life care. | ||
670 | ‡a Author's Using routine data to estimate survival and recurrence in head and neck cancer: our preliminary experience in twenty patients. | ||
909 | ‡a (orcid) 0000000170960718 ‡9 1 | ||
919 | ‡a usingroutinedatatoestimatesurvivalandrecurrenceinheadandneckcancerourpreliminaryexperiencein20patients ‡A Using routine data to estimate survival and recurrence in head and neck cancer: our preliminary experience in twenty patients. ‡9 1 | ||
919 | ‡a routineclinicaldatapredictsurvivalafterpalliativeradiotherapyanopportunitytoimproveendoflifecare ‡A Routine clinical data predict survival after palliative radiotherapy: an opportunity to improve end of life care. ‡9 1 | ||
919 | ‡a radiotherapymightnotbetheanswerinafrica ‡A Radiotherapy might not be the answer in Africa ‡9 1 | ||
919 | ‡a malignantspinalcordcompressionniceguidanceimprovementsandchallenges ‡A Malignant spinal cord compression: NICE guidance, improvements and challenges ‡9 1 | ||
919 | ‡a integratedsystemsgeneticanalysesrevealanetworktargetfordelayinggliomaprogression ‡A Integrated systems-genetic analyses reveal a network target for delaying glioma progression ‡9 1 | ||
919 | ‡a glioblastomainengland2007 ‡A Glioblastoma in England: 2007-2011. ‡9 1 | ||
919 | ‡a fractionatedstereotacticradiotherapyforacousticneuromaslongtermoutcomes ‡A Fractionated stereotactic radiotherapy for acoustic neuromas: long-term outcomes ‡9 1 | ||
919 | ‡a estimatingtherisksfromcovid19infectioninadultchemotherapypatients ‡A Estimating the Risks from COVID-19 Infection in Adult Chemotherapy Patients ‡9 1 | ||
919 | ‡a computerprogrammingshouldmedicalstudentsbelearningit ‡A Computer Programming: Should Medical Students Be Learning It? ‡9 1 | ||
919 | ‡a changeinplateletlevelsduringradiotherapywithconcurrentandadjuvanttemozolomideforthetreatmentofglioblastomaanovelprognosticfactorforsurvival ‡A Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival. ‡9 1 | ||
919 | ‡a phase1studyofpegylatedargininedeiminasepegargiminasecisplatinandpemetrexedinargininosuccinatesynthetase1deficientrecurrenthighgradeglioma ‡A A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma ‡9 1 | ||
919 | ‡a aggregatingevidenceaboutthepositiveandnegativeeffectsoftreatments ‡A Aggregating evidence about the positive and negative effects of treatments. ‡9 1 | ||
943 | ‡a 201x ‡A 2011 ‡9 1 | ||
996 | ‡2 LC|n 2015069690 | ||
996 | ‡2 PLWABN|9810552793705606 | ||
996 | ‡2 ISNI|0000000035552084 | ||
996 | ‡2 SUDOC|274971186 | ||
996 | ‡2 CAOONL|ncf12066951 | ||
996 | ‡2 LC|no2013044821 | ||
996 | ‡2 LC|no2009048430 | ||
996 | ‡2 ISNI|0000000047107543 | ||
996 | ‡2 ISNI|0000000049416593 | ||
996 | ‡2 NUKAT|n 2019170129 | ||
996 | ‡2 LC|no2010084990 | ||
996 | ‡2 LC|no2024019807 | ||
996 | ‡2 BNF|15742768 | ||
996 | ‡2 ISNI|0000000065714275 | ||
996 | ‡2 ISNI|0000000403559096 | ||
996 | ‡2 LC|no2016091237 | ||
996 | ‡2 LC|no2017029492 | ||
996 | ‡2 LC|n 96000313 | ||
996 | ‡2 N6I|vtls002775683 | ||
996 | ‡2 LC|no2002094929 | ||
996 | ‡2 DNB|1112634630 | ||
996 | ‡2 DNB|120013883X | ||
996 | ‡2 BIBSYS|6087547 | ||
996 | ‡2 BNF|17938327 | ||
996 | ‡2 NKC|xx0225148 | ||
996 | ‡2 PLWABN|9813264591005606 | ||
996 | ‡2 PLWABN|9813990245305606 | ||
996 | ‡2 LC|n 2001026370 | ||
996 | ‡2 NTA|408176148 | ||
996 | ‡2 ISNI|0000000119832729 | ||
996 | ‡2 NTA|214115410 | ||
996 | ‡2 BIBSYS|90158743 | ||
996 | ‡2 SIMACOB|98200931 | ||
996 | ‡2 NUKAT|n 2008052257 | ||
996 | ‡2 LC|n 2013023777 | ||
996 | ‡2 DNB|1146973098 | ||
996 | ‡2 SUDOC|184429358 | ||
996 | ‡2 NDL|032765652 | ||
996 | ‡2 DNB|1074309456 | ||
996 | ‡2 ISNI|0000000067161299 | ||
996 | ‡2 ISNI|0000000047923364 | ||
996 | ‡2 LC|no2003052320 | ||
996 | ‡2 DNB|1206372796 | ||
996 | ‡2 DNB|13296404X | ||
996 | ‡2 DNB|118004908X | ||
996 | ‡2 J9U|987007306940005171 | ||
996 | ‡2 LC|n 2005081179 | ||
996 | ‡2 SUDOC|267794908 | ||
996 | ‡2 ISNI|0000000038865246 | ||
996 | ‡2 LC|n 80021285 | ||
996 | ‡2 BIBSYS|90408578 | ||
996 | ‡2 LC|n 2021015507 | ||
996 | ‡2 SUDOC|204772311 | ||
996 | ‡2 NYNYRILM|199594 | ||
996 | ‡2 LC|no2016058862 | ||
996 | ‡2 LC|n 99274598 | ||
996 | ‡2 NUKAT|nx2023730863 | ||
996 | ‡2 ISNI|0000000501785767 | ||
996 | ‡2 BIBSYS|8080383 | ||
996 | ‡2 ISNI|0000000040770924 | ||
996 | ‡2 DNB|1186088982 | ||
996 | ‡2 DNB|1212209303 | ||
996 | ‡2 LC|n 2014050338 | ||
996 | ‡2 DBC|87097969752012 | ||
996 | ‡2 NII|DA17481129 | ||
996 | ‡2 DNB|143539396 | ||
996 | ‡2 SUDOC|15417033X | ||
996 | ‡2 ISNI|0000000079136680 | ||
996 | ‡2 LC|no2011072651 | ||
996 | ‡2 DNB|131907182 | ||
996 | ‡2 RERO|A009067341 | ||
996 | ‡2 CAOONL|ncf11354190 | ||
996 | ‡2 LC|n 2011014581 | ||
996 | ‡2 LC|n 00122112 | ||
996 | ‡2 LC|no2022062383 | ||
996 | ‡2 DNB|1283685515 | ||
996 | ‡2 LC|no2019123744 | ||
996 | ‡2 ISNI|000000043502423X | ||
996 | ‡2 LC|no2014035742 | ||
996 | ‡2 DNB|1089279302 | ||
996 | ‡2 LC|nb2018013218 | ||
996 | ‡2 RERO|A022945267 | ||
996 | ‡2 LC|nb2016017334 | ||
996 | ‡2 DBC|87097969752004 | ||
996 | ‡2 PLWABN|9810614267405606 | ||
996 | ‡2 ISNI|0000000078726232 | ||
996 | ‡2 LC|nb2016014019 | ||
996 | ‡2 LC|nb2001041801 | ||
996 | ‡2 LC|n 2008006527 | ||
996 | ‡2 LC|n 86846370 | ||
996 | ‡2 NSK|000067063 | ||
996 | ‡2 ISNI|000000002770085X | ||
996 | ‡2 CAOONL|ncf11308270 | ||
996 | ‡2 ISNI|0000000452958077 | ||
996 | ‡2 BNF|13815566 | ||
996 | ‡2 LNB|LNC10-000207981 | ||
996 | ‡2 LC|n 97084381 | ||
996 | ‡2 LC|nb2008011277 | ||
996 | ‡2 CAOONL|ncf10722472 | ||
996 | ‡2 PLWABN|9814024577205606 | ||
996 | ‡2 LC|no2019098762 | ||
996 | ‡2 SUDOC|257255257 | ||
996 | ‡2 LC|no2009148089 | ||
996 | ‡2 BNE|XX1521268 | ||
996 | ‡2 NLA|000035480776 | ||
996 | ‡2 DNB|134697871 | ||
996 | ‡2 LC|nb2021012352 | ||
996 | ‡2 SUDOC|257630694 | ||
996 | ‡2 RERO|A013992426 | ||
996 | ‡2 ISNI|0000000357634234 | ||
996 | ‡2 NII|DA15505871 | ||
996 | ‡2 NUKAT|n 2018152256 | ||
996 | ‡2 RERO|A009181107 | ||
996 | ‡2 LC|n 84211360 | ||
996 | ‡2 ISNI|0000000051594882 | ||
996 | ‡2 BIBSYS|8003172 | ||
996 | ‡2 LC|n 2022183379 | ||
996 | ‡2 DNB|116725340X | ||
996 | ‡2 NKC|ola20231195441 | ||
996 | ‡2 SIMACOB|121925219 | ||
996 | ‡2 LC|nb2008004119 | ||
996 | ‡2 CAOONL|ncf11484542 | ||
996 | ‡2 SUDOC|23751978X | ||
996 | ‡2 DNB|1144978092 | ||
996 | ‡2 LC|n 2006008206 | ||
996 | ‡2 PTBNP|1845152 | ||
996 | ‡2 ISNI|0000000363316961 | ||
996 | ‡2 ISNI|0000000377866251 | ||
996 | ‡2 LC|nb2008026389 | ||
996 | ‡2 BNF|14145892 | ||
996 | ‡2 LC|no2020015467 | ||
996 | ‡2 BIBSYS|99070995 | ||
996 | ‡2 LC|n 82087945 | ||
996 | ‡2 J9U|987007354633905171 | ||
996 | ‡2 DNB|1205003460 | ||
996 | ‡2 RERO|A003977305 | ||
996 | ‡2 BIBSYS|8023209 | ||
996 | ‡2 NUKAT|n 2008052961 | ||
996 | ‡2 LC|nr 87001051 | ||
996 | ‡2 NUKAT|n 2018154700 | ||
996 | ‡2 BIBSYS|6024878 | ||
996 | ‡2 BIBSYS|10026801 | ||
996 | ‡2 LC|nb2019008197 | ||
996 | ‡2 ISNI|0000000459363674 | ||
996 | ‡2 LC|nb2022006787 | ||
996 | ‡2 ISNI|0000000392275302 | ||
996 | ‡2 LC|no2013052405 | ||
996 | ‡2 BNF|16551234 | ||
996 | ‡2 ISNI|0000000403340713 | ||
996 | ‡2 LC|n 2005085417 | ||
996 | ‡2 BIBSYS|13023844 | ||
996 | ‡2 LC|n 85096024 | ||
996 | ‡2 NSK|000527741 | ||
996 | ‡2 LC|n 94114086 | ||
996 | ‡2 BIBSYS|90300851 | ||
996 | ‡2 NTA|172857082 | ||
996 | ‡2 ISNI|0000000115936141 | ||
996 | ‡2 LC|nr 93043015 | ||
996 | ‡2 ISNI|0000000045164309 | ||
996 | ‡2 ISNI|0000000059173775 | ||
996 | ‡2 J9U|987007323148905171 | ||
996 | ‡2 SUDOC|199731349 | ||
996 | ‡2 ISNI|0000000507137939 | ||
996 | ‡2 NSK|000258178 | ||
996 | ‡2 ISNI|0000000032013384 | ||
996 | ‡2 BNF|16557962 | ||
996 | ‡2 J9U|987007338243705171 | ||
996 | ‡2 ISNI|0000000047732533 | ||
996 | ‡2 BNF|13620783 | ||
996 | ‡2 ISNI|0000000114584519 | ||
996 | ‡2 DNB|1165355183 | ||
996 | ‡2 J9U|987007320662805171 | ||
996 | ‡2 DNB|1311022511 | ||
996 | ‡2 LC|n 83169204 | ||
996 | ‡2 NTA|324148259 | ||
996 | ‡2 LC|n 2017046830 | ||
996 | ‡2 LC|n 2018062247 | ||
996 | ‡2 ISNI|0000000497402988 | ||
996 | ‡2 LC|no2020043549 | ||
996 | ‡2 NLA|000035149590 | ||
996 | ‡2 SUDOC|146836049 | ||
996 | ‡2 ISNI|0000000038487062 | ||
996 | ‡2 SZ|1144978092 | ||
996 | ‡2 NUKAT|n 2007120245 | ||
996 | ‡2 SUDOC|129856479 | ||
996 | ‡2 SUDOC|187873038 | ||
996 | ‡2 ISNI|0000000497094073 | ||
996 | ‡2 LC|nb2009027726 | ||
996 | ‡2 LC|nb2018018989 | ||
996 | ‡2 LC|n 2004037646 | ||
996 | ‡2 ISNI|0000000514193023 | ||
996 | ‡2 NUKAT|n 99092001 | ||
996 | ‡2 ISNI|000000050136791X | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |